Summary: Forbes reports on the progress of MDMA-assisted psychotherapy research in Israel, highlighting news of the first two Israeli participants to complete treatment in MAPS’ Phase 3 clinical trial of MDMA-assisted psychotherapy for PTSD and the Israeli government’s support of MDMA research. “Israel is the first national government to financially support MDMA-assisted psychotherapy research,” explains David E. Carpenter of Forbes.
Originally appearing here.